Nuvilex has named Gerald W. Crabtree chief operating officer.

Since 1985, Dr. Crabtree has been involved with various biopharmaceutical companies where he has supervised and coordinated the development of multiple drug candidates, prepared clinical protocols, investigator brochures, monographs, research and review articles, and served as project manager in major oncologic agent development. Most recently, Dr. Crabtree served as interim CEO of PhytoCeutica.